First Turn Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
First Turn Management, LLC
- $615 Billion
- Q2 2024
A detailed history of First Turn Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, First Turn Management, LLC holds 703,398 shares of MIRM stock, worth $27.9 Million. This represents 3.91% of its overall portfolio holdings.
Number of Shares
703,398
Previous 958,654
26.63%
Holding current value
$27.9 Million
Previous $24.1 Billion
0.13%
% of portfolio
3.91%
Previous 3.6%
Shares
3 transactions
Others Institutions Holding MIRM
# of Institutions
173Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$257 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$198 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$173 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$143 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$128 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.46B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...